United States · Bill · HR
H.R. 7071 (116th)
Accelerating Access to Critical Therapies for ALS Act
Introduced
1 June 2020
Last action
1 June 2020 · Introduced
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
Rep. Fortenberry, Jeff [R-NE-1], Rep. Quigley, Mike [D-IL-5], Rep. Higgins, Clay [R-LA-3], Rep. Schweikert, David [R-AZ-1], Rep. Rouda, Harley [D-CA-48], Rep. Crow, Jason [D-CO-6], Rep. Sewell, Terri A. [D-AL-7], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Calvert, Ken [R-CA-41], Rep. Hill, J. French [R-AR-2], Rep. Neguse, Joe [D-CO-2], Rep. Crawford, Eric A. "Rick" [R-AR-1], Rep. Harris, Andy [R-MD-1], Rep. Womack, Steve [R-AR-3], Paul Cook, Rep. Cole, Tom [R-OK-4], Rep. Brooks, Mo [R-AL-5], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Rep. Sires, Albio [D-NJ-13], Rep. King, Steve [R-IA-4], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Beatty, Joyce [D-OH-3], Rep. Davis, Rodney [R-IL-13], Rep. Golden, Jared F. [D-ME-2], Rep. Scanlon, Mary Gay [D-PA-5], Rep. Stivers, Steve [R-OH-15], Rep. Westerman, Bruce [R-AR-4], Rep. Stanton, Greg [D-AZ-4], Rep. Holding, George [R-NC-2], Rep. Timmons, William R. [R-SC-4], Rep. Moolenaar, John R. [R-MI-2], Rep. King, Peter T. [R-NY-2], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Meeks, Gregory W. [D-NY-5], Rep. Turner, Michael R. [R-OH-10], Rep. McClintock, Tom [R-CA-5], Rep. O'Halleran, Tom [D-AZ-1], Denver Riggleman, Rep. DesJarlais, Scott [R-TN-4], Rep. Langevin, James R. [D-RI-2], Rep. Luria, Elaine G. [D-VA-2], Rep. Green, Al [D-TX-9], Rep. Soto, Darren [D-FL-9], Rep. Peterson, Collin C. [D-MN-7], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. Katko, John [R-NY-24], Rep. Tlaib, Rashida [D-MI-12], Rep. Payne, Donald M., Jr. [D-NJ-10]
Subjects
Healthcare
Source updated
3 January 2025
Summary
Accelerating Access to Critical Therapies for ALS Act This bill establishes a grant program, as well as a new center within the Food and Drug Administration (FDA), to facilitate access to investigational therapies for neurodegenerative diseases such as amyotrophic lateral sclerosis (i.e., ALS, also known as Lou Gehrig's disease, a progressive and fatal disease). Specifically, the Department of Health and Human Services (HHS) must award grants for the provision of investigational drugs for ALS and other rapidly progressing neurodegenerative diseases through an expanded access (i.e., compassionate use) program. HHS may award these grants to (1) a small business that is the sponsor of an investigational new drug application, or (2) a participating clinical trial site for such a sponsor. Additionally, HHS must establish within the FDA a Center of Excellence for Neurodegenerative Diseases. The center shall have duties and authorities similar to those of the FDA's Oncology Center of Excellence, which helps expedite the development of medical products and assists providers in requesting access to investigational drugs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 June 2020
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
1 June 2020
Introduced
Introduced in House
Source: IntroReferral
1 June 2020
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 1 June 2020 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 1 June 2020
Introduced in House (PDF)
Introduced in House · EN · 1 June 2020
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 1 June 2020
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Fortenberry, Jeff [R-NE-1] · R · Sponsor
- Rep. Quigley, Mike [D-IL-5] · D · Sponsor
- Rep. Higgins, Clay [R-LA-3] · R · Cosponsor
- Rep. Schweikert, David [R-AZ-1] · R · Cosponsor
- Rep. Rouda, Harley [D-CA-48] · D · Cosponsor
- Rep. Crow, Jason [D-CO-6] · D · Cosponsor
- Rep. Sewell, Terri A. [D-AL-7] · D · Cosponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Cosponsor
- Rep. Calvert, Ken [R-CA-41] · R · Cosponsor
- Rep. Hill, J. French [R-AR-2] · R · Cosponsor
- Rep. Neguse, Joe [D-CO-2] · D · Cosponsor
- Rep. Crawford, Eric A. "Rick" [R-AR-1] · R · Cosponsor
- Rep. Harris, Andy [R-MD-1] · R · Cosponsor
- Rep. Womack, Steve [R-AR-3] · R · Cosponsor
- Paul Cook · R · Cosponsor
- Rep. Cole, Tom [R-OK-4] · R · Cosponsor
- Rep. Brooks, Mo [R-AL-5] · R · Cosponsor
- Rep. Fleischmann, Charles J. "Chuck" [R-TN-3] · R · Cosponsor
- Rep. Sires, Albio [D-NJ-13] · D · Cosponsor
- Rep. King, Steve [R-IA-4] · R · Cosponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · R · Cosponsor
- Rep. Beatty, Joyce [D-OH-3] · D · Cosponsor
- Rep. Davis, Rodney [R-IL-13] · R · Cosponsor
- Rep. Golden, Jared F. [D-ME-2] · D · Cosponsor
- Rep. Scanlon, Mary Gay [D-PA-5] · D · Cosponsor
- Rep. Stivers, Steve [R-OH-15] · R · Cosponsor
- Rep. Westerman, Bruce [R-AR-4] · R · Cosponsor
- Rep. Stanton, Greg [D-AZ-4] · D · Cosponsor
- Rep. Holding, George [R-NC-2] · R · Cosponsor
- Rep. Timmons, William R. [R-SC-4] · R · Cosponsor
- Rep. Moolenaar, John R. [R-MI-2] · R · Cosponsor
- Rep. King, Peter T. [R-NY-2] · R · Cosponsor
- Rep. Ruppersberger, C. A. Dutch [D-MD-2] · D · Cosponsor
- Rep. Meeks, Gregory W. [D-NY-5] · D · Cosponsor
- Rep. Turner, Michael R. [R-OH-10] · R · Cosponsor
- Rep. McClintock, Tom [R-CA-5] · R · Cosponsor
- Rep. O'Halleran, Tom [D-AZ-1] · D · Cosponsor
- Denver Riggleman · R · Cosponsor
- Rep. DesJarlais, Scott [R-TN-4] · R · Cosponsor
- Rep. Langevin, James R. [D-RI-2] · D · Cosponsor
- Rep. Luria, Elaine G. [D-VA-2] · D · Cosponsor
- Rep. Green, Al [D-TX-9] · D · Cosponsor
- Rep. Soto, Darren [D-FL-9] · D · Cosponsor
- Rep. Peterson, Collin C. [D-MN-7] · D · Cosponsor
- Rep. Cisneros, Gilbert Ray [D-CA-31] · D · Cosponsor
- Rep. Katko, John [R-NY-24] · R · Cosponsor
- Rep. Tlaib, Rashida [D-MI-12] · D · Cosponsor
- Rep. Payne, Donald M., Jr. [D-NJ-10] · D · Cosponsor
Showing 48 of 200 sponsors and actors.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/7071
- Open data entity: https://api.congress.gov/v3/bill/116/hr/7071
- us · 116-hr-7071 · source updated 3 January 2025